The notices it replaced
- Reissues: RFA-CA-25-002 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- 2 steps back: RFA-CA-24-009 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- 3 steps back: RFA-CA-23-003 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- 4 steps back: RFA-CA-22-002 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- 5 steps back: RFA-CA-21-004 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- 6 steps back: RFA-CA-20-018 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
- 7 steps back: RFA-CA-19-020 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
- 8 steps back: RFA-CA-18-003 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)
- 9 steps back: RFA-CA-17-011 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
- 10 steps back: RFA-CA-16-002 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
- 11 steps back: RFA-CA-15-003 Advanced Development and Validation of Emerging Molecular Analysis Technologies for Cancer Research (R33)
- 12 steps back: RFA-CA-14-004 Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33)
- 13 steps back: RFA-CA-13-002 Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33)
- 14 steps back: RFA-CA-12-003 Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
- 15 steps back: RFA-CA-10-004 Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
- 16 steps back: RFA-CA-09-007 Application and Use of Transformative Emerging Technologies in Cancer Research (R33)
- 17 steps back: RFA-CA-08-008
- 18 steps back: RFA-CA-07-036
- 19 steps back: RFA-CA-07-018
- 20 steps back: RFA-CA-07-002
- 21 steps back: RFA-CA-06-003
- 22 steps back: RFA-CA-05-003
Who won it before
128 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $54,765,579 in first-year total cost, median $391,290.
Most frequent study sections
- Special Emphasis Panel[ZCA1 TCRB-J (M1)]15
- Special Emphasis Panel[ZCA1 TCRB-J (J1)]14
- Special Emphasis Panel[ZCA1 TCRB-Q (O2)]13
- Special Emphasis Panel[ZCA1 TCRB-D (O1)]11
- Special Emphasis Panel[ZCA1 TCRB-D (M1)]9
Most frequent institutions
- UNIVERSITY OF WASHINGTON6
- YALE UNIVERSITY6
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS4
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY4
- STANFORD UNIVERSITY4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Single-cell (phospho-)proteomics platform for functional analysis of tumor microenvironment1R33CA287139-01A1 · under RFA-CA-24-009 | SHI, TUJIN | BATTELLE PACIFIC NORTHWEST LABORATORIES, WA | $450,904 | ZCA1 |
| 2025 | Advanced Development of Patient Ascites Therapeutic Response Biosensors1R33CA291166-01A1 · under RFA-CA-24-009 | BOEHM, JESSE SAMUELCIMINI, BETHKLEMPNER, SAMUEL J | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $419,133 | ZCA1 |
| 2025 | Precision single-cell mapping of chromatin-associated protein activity by molecular footprinting to chart disruptions to gene regulation and dissect tumor heterogeneity in cancer1R33CA302607-01 · under RFA-CA-24-009 | LANDAU, DAN | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $401,829 | ZCA1 |
| 2025 | Microbiome-Mediated Tumor Immunomodulation in a Pathomimetic Colorectal Cancer Chip1R33CA286797-01A1 · under RFA-CA-24-009 | KIM, HYUN JUNG | CLEVELAND CLINIC LERNER COM-CWRU, OH | $400,890 | ZCA1 |
| 2025 | Sequence optimization for mRNA cancer therapy1R33CA286947-01A1 · under RFA-CA-24-009 | SEELIG, GEORG | UNIVERSITY OF WASHINGTON, WA | $380,337 | ZCA1 |
| 2025 | Spatiomolecular Profiling of Human Cancer at Scale1R33CA297902-01A1 · under RFA-CA-24-009 | CHEVRIER, NICOLAS | UNIVERSITY OF CHICAGO, IL | $372,628 | ZCA1 |
| 2025 | Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation1R33CA302385-01 · under RFA-CA-24-009 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON, WA | $369,468 | ZCA1 |
| 2025 | Next generation platforms for interrogating TCR specificity1R33CA302206-01 · under RFA-CA-24-009 | GARCIA, KENAN CHRISTOPHER | STANFORD UNIVERSITY, CA | $368,294 | ZCA1 |
| 2024 | A platform for multi-modal single nucleus spatial genomics for molecular tumor analysis1R33CA291199-01 · under RFA-CA-23-003 | CHEN, FEI | BROAD INSTITUTE, INC., MA | $417,586 | ZCA1 |
| 2024 | Nano-CRISPR extracellular vesicle sensing system for longitudinal tumor monitoring1R33CA281794-01A1 · under RFA-CA-23-003 | IM, HYUNGSOON | MASSACHUSETTS GENERAL HOSPITAL, MA | $415,830 | ZCA1 |
| 2024 | Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis1R33CA278564-01A1 · under RFA-CA-23-003 | BREUNIG, JOSHUA JOHN | CEDARS-SINAI MEDICAL CENTER, CA | $414,491 | ZCA1 |
| 2024 | An integrated functional proteomics platform for accelerated discovery of isoform-specific determinants of cancer1R33CA281919-01A1 · under RFA-CA-23-003 | SHEYNKMAN, GLORIAYI, S. STEPHEN | UNIVERSITY OF VIRGINIA, VA | $412,365 | ZCA1 |
| 2024 | Bio-orthogonal Mid-Infrared Photothermal Imaging of Cancer Metabolism1R33CA287046-01A1 · under RFA-CA-23-003 | CHENG, JI-XIN | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $407,113 | ZCA1 |
| 2024 | Develop and validate demineralized bone paper-based human bone metabolic and senolytic assays1R33CA291301-01 · under RFA-CA-23-003 | LEE, JUNGWOO | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $394,482 | ZCA1 |
| 2024 | High Throughput Digital Droplet Assays for Ultrasensitive Multimodal (DNA, RNA, and Protein) Diagnostics1R33CA287135-01 · under RFA-CA-23-003 | ISSADORE, DAVID AARON | UNIVERSITY OF PENNSYLVANIA, PA | $389,746 | ZCA1 |
| 2024 | Spatial protein-protein interaction networks in situ by multiplexed proximity ligation1R33CA291197-01 · under RFA-CA-23-003 | COSKUN, AHMET F. | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $374,123 | ZCA1 |
| 2024 | Quantification of molecular interactions across the matrix spectrum enables cancer research.1R33CA291185-01 · under RFA-CA-23-003 | BORNHOP, DARRYL J. | VANDERBILT UNIVERSITY, TN | $335,944 | ZCA1 |
| 2024 | 3D Proteomics at Single Cell Resolution with Covalent Protein Painting (CPP)1R33CA272339-01A1 · under RFA-CA-23-003 | YATES III, JOHN R | SCRIPPS RESEARCH INSTITUTE, THE, CA | $240,092 | ZCA1 |
| 2023 | Clonal analysis of cancer by mitochondrial DNA barcoding1R33CA278393-01 · under RFA-CA-22-002 | SANKARAN, VIJAY GANESHVAN GALEN, PETER | BRIGHAM AND WOMEN'S HOSPITAL, MA | $462,970 | ZCA1 |
| 2023 | A platform to identify in vivo targets of covalent cancer drugs in 3D tissues1R33CA281918-01 · under RFA-CA-22-002 | CRAVATT, BENJAMIN FYE, LI | SCRIPPS RESEARCH INSTITUTE, THE, CA | $450,690 | ZCA1 |
| 2023 | Advanced development of composite gene delivery and CAR engineering systems1R33CA281702-01 · under RFA-CA-22-002 | CHEN, SIDI | YALE UNIVERSITY, CT | $417,075 | ZCA1 |
| 2023 | Bioorthogonal probe development for highly parallel in vivo imaging1R33CA277820-01 · under RFA-CA-22-002 | WEISSLEDER, MD, PHD, RALPH | MASSACHUSETTS GENERAL HOSPITAL, MA | $415,830 | ZCA1 |
| 2023 | Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy1R33CA272271-01A1 · under RFA-CA-22-002 | CUNNINGHAM, BRIAN T.MANSFIELD, AARON SCOTTWANG, XING | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $391,467 | ZCA1 |
| 2023 | Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck1R33CA281802-01 · under RFA-CA-22-002 | LABAER, JOSHUA | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $390,906 | ZCA1 |
| 2023 | Combining Machine Learning and Nanofluidic Technology for The Multiplexed Diagnosis of Pancreatic Adenocarcinoma1R33CA278551-01 · under RFA-CA-22-002 | CARPENTER, ERICAISSADORE, DAVID AARON | UNIVERSITY OF PENNSYLVANIA, PA | $388,274 | ZCA1 |
| 2023 | Engineering Protein Modulators of Notch Activation for T-cell immunotherapy1R33CA272331-01A1 · under RFA-CA-22-002 | GORDON, WENDY RYANMURETTA, JOSEPH M. | UNIVERSITY OF MINNESOTA, MN | $384,750 | ZCA1 |
| 2023 | Single cell modeling of cancer mutations1R33CA278469-01 · under RFA-CA-22-002 | JI, HANLEE P | STANFORD UNIVERSITY, CA | $375,297 | ZCA1 |
| 2023 | A High-Throughput Screening Platform to Discover RNA Methylation Inhibitors1R33CA281602-01 · under RFA-CA-22-002 | MEYER, KATHRYN D | DUKE UNIVERSITY, NC | $372,790 | ZCA1 |
| 2023 | Micro-capsules for versatile multiplexed cytometry1R33CA278392-01 · under RFA-CA-22-002 | KLEIN, ALLON MOSHEMAZUTIS, LINAS | HARVARD MEDICAL SCHOOL, MA | $370,215 | ZCA1 |
| 2022 | Systematic characterization of cancer variants using single-cell functional genomics1R33CA267221-01 · under RFA-CA-21-004 | LOWE, SCOTT W.NORMAN, THOMAS MAXWELL | SLOAN-KETTERING INST CAN RESEARCH, NY | $440,728 | ZCA1 |
| 2022 | A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies1R33CA272321-01 · under RFA-CA-21-004 | PISANIC II, THOMAS RUSSELLWANG, TZA-HUEI JEFF | JOHNS HOPKINS UNIVERSITY, MD | $433,765 | ZCA1 |
| 2022 | A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research1R33CA269100-01 · under RFA-CA-21-004 | CHIU, BRIAN C-HZHANG, WEI | UNIVERSITY OF CHICAGO, IL | $421,166 | ZCA1 |
| 2022 | Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes1R33CA267219-01A1 · under RFA-CA-21-004 | LANDAU, DAN | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $419,174 | ZCA1 |
| 2022 | Transfer RNA sequencing and application to cancer research and clinics1R33CA272357-01 · under RFA-CA-21-004 | BISSONNETTE, BRUCE MARCPAN, TAOSHOGAN, BENJAMIN | UNIVERSITY OF CHICAGO, IL | $405,277 | ZCA1 |
| 2022 | Optogenetic Control of Tumor Initiation and Tumor Progression in vivo1R33CA258012-01A1 · under RFA-CA-21-004 | KARGINOV, ANDREI VREHMAN, JALEES | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $403,638 | ZCA1 |
| 2022 | Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence1R33CA261696-01A1 · under RFA-CA-21-004 | MERAJVER, SOFIA DIANAOLIVER, CHRISTOPHER RYAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $388,438 | ZCA1 |
| 2022 | Accessible high-throughput single-cell genome sequencing1R33CA269015-01 · under RFA-CA-21-004 | ADEY, ANDREW | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $379,328 | ZCA1 |
| 2022 | A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides1R33CA259451-01A1 · under RFA-CA-21-004 | NAEGLE, KRISTEN M | UNIVERSITY OF VIRGINIA, VA | $378,839 | ZCA1 |
| 2022 | Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues1R33CA269094-01 · under RFA-CA-21-004 | MOELLERING, RAYMOND E | UNIVERSITY OF CHICAGO, IL | $373,510 | ZCA1 |
| 2022 | Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy1R33CA267258-01A1 · under RFA-CA-21-004 | AGRAWAL, ANSHULEE, ABRAHAM P | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $367,506 | ZCA1 |
| 2022 | Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids1R33CA267226-01 · under RFA-CA-21-004 | DRAKE, RICHARD R. | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $337,036 | ZCA1 |
| 2021 | Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy1R33CA256112-01A1 · under RFA-CA-20-018 | WEI, WEI | INSTITUTE FOR SYSTEMS BIOLOGY, WA | $462,881 | ZCA1 |
| 2021 | Joint receptor and protein expression immunophenotyping through split-pool barcoding1R33CA255893-01 · under RFA-CA-20-018 | SEELIG, GEORG | UNIVERSITY OF WASHINGTON, WA | $427,567 | ZCA1 |
| 2021 | Universal Sample Multiplexing for Single Cell Analysis1R33CA247744-01A1 · under RFA-CA-20-018 | GARTNER, ZEV JORDAN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $398,629 | ZCA1 |
| 2021 | Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy1R33CA261726-01 · under RFA-CA-20-018 | CHENG, JI-XIN | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $398,440 | ZCA1 |
| 2021 | A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells1R33CA256086-01A1 · under RFA-CA-20-018 | BROCK, AMYJIANG, NING JENNY | UNIVERSITY OF PENNSYLVANIA, PA | $394,894 | ZCA1 |
| 2021 | Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics1R33CA258016-01 · under RFA-CA-20-018 | LIU, XUEFENG | OHIO STATE UNIVERSITY, OH | $390,660 | ZCA1 |
| 2021 | Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer1R33CA257878-01 · under RFA-CA-20-018 | HANSEN, ANDERS SEJR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $379,981 | ZCA1 |
| 2021 | Multimodal iterative sequencing of cancer genomes and single tumor cells1R33CA247700-01A1 · under RFA-CA-20-018 | JI, HANLEE P | STANFORD UNIVERSITY, CA | $365,977 | ZCA1 |
| 2021 | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens1R33CA256102-01 · under RFA-CA-20-018 | GREENBERG, JOELKAPADIA, ANUJ J. | DUKE UNIVERSITY, NC | $360,935 | ZCA1 |
| 2021 | Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles1R33CA252158-01A1 · under RFA-CA-20-018 | XU, LIANGZENG, YONG | UNIVERSITY OF FLORIDA, FL | $354,506 | ZCA1 |
| 2020 | T-cell Biofactories for targeting extracellular matrix1R33CA247739-01 · under RFA-CA-19-020 | BHATNAGAR, PARIJAT | SRI INTERNATIONAL, CA | $1,606,207 | ZCA1 |
| 2020 | Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer1R33CA236681-01A1 · under RFA-CA-19-020 | VERHAAK, ROEL GWWEI, CHIA-LIN | JACKSON LABORATORY, ME | $1,377,810 | ZCA1 |
| 2020 | Comprehensive breakpoint analyses for simultaneous quantification of all DNA double strand break repair pathways1R33CA236670-01A1 · under RFA-CA-19-020 | HIGGINSON, DANIEL | SLOAN-KETTERING INST CAN RESEARCH, NY | $1,322,190 | ZCA1 |
| 2020 | Multiplexed imaging of chromatin folding and RNA profiles in cancer1R33CA251037-01 · under RFA-CA-19-020 | MUZUMDAR, MANDAR DEEPAKWANG, SIYUAN | YALE UNIVERSITY, CT | $1,237,899 | ZCA1 |
| 2020 | Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores1R33CA246448-01A1 · under RFA-CA-19-020 | HALL, ADAM ROGER | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $1,089,730 | ZCA1 |
| 2020 | High-Throughput Screening Platform for Cancer Drug Discovery1R33CA240191-01A1 · under RFA-CA-19-020 | RECHT, MICHAEL | PALO ALTO RESEARCH CENTER, CA | $720,575 | ZCA1 |
| 2020 | Clinical implementations of spatial transcriptomics in tumors1R33CA246455-01 · under RFA-CA-19-020 | ASHENBERG, ORRCHEN, FEIRODIG, SCOTT J | BROAD INSTITUTE, INC., MA | $449,518 | ZCA1 |
| 2020 | High-throughput single-cell co-sequencing of small and large RNAs to identify molecular circuitry in cancer1R33CA246711-01 · under RFA-CA-19-020 | FAN, RONGLU, JUN | YALE UNIVERSITY, CT | $417,077 | ZCA1 |
| 2020 | Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies1R33CA240181-01A1 · under RFA-CA-19-020 | CHAICHANA, KAISORN LEECOOKS, ROBERT GRAHAMQUINONES-HINOJOSA, ALFREDO | PURDUE UNIVERSITY, IN | $392,146 | ZCA1 |
| 2020 | A Virion-Display Oscillator Array and Detection Platform for Quantification of Transmembrane Protein Binding Kinetics1R33CA235294-01A1 · under RFA-CA-19-020 | WANG, SHAOPENG | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $391,113 | ZCA1 |
| 2020 | Time-resolved FRET-based allostery sensors for any protein kinase drug target1R33CA246363-01 · under RFA-CA-19-020 | LEVINSON, NICHOLAS MARK | UNIVERSITY OF MINNESOTA, MN | $375,535 | ZCA1 |
| 2019 | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery1R33CA225549-01A1 · under RFA-CA-18-003 | LUKER, GARY DTAVANA, HOSSEIN | UNIVERSITY OF AKRON, OH | $476,844 | ZCA1 |
| 2019 | A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells1R33CA229042-01A1 · under RFA-CA-18-003 | SCHNECK, JONATHAN P | JOHNS HOPKINS UNIVERSITY, MD | $416,450 | ZCA1 |
| 2019 | GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models1R33CA236687-01 · under RFA-CA-18-003 | BREUNIG, JOSHUA JOHN | CEDARS-SINAI MEDICAL CENTER, CA | $413,100 | ZCA1 |
| 2019 | Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation1R33CA229068-01A1 · under RFA-CA-18-003 | SCHIAVINATO EBERLIN, LIVIA | UNIVERSITY OF TEXAS AT AUSTIN, TX | $411,941 | ZCA1 |
| 2019 | Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment1R33CA235319-01A1 · under RFA-CA-18-003 | YANG, JENNY J. | GEORGIA STATE UNIVERSITY, GA | $407,268 | ZCA1 |
| 2019 | Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers1R33CA225498-01A1 · under RFA-CA-18-003 | CHEN, SIDI | YALE UNIVERSITY, CT | $407,025 | ZCA1 |
| 2019 | Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics1R33CA225458-01A1 · under RFA-CA-18-003 | GERBER, SCOTT A.KETTENBACH, ARMINJA NADINE | DARTMOUTH COLLEGE, NH | $400,114 | ZCA1 |
| 2019 | Optimization and validation of integrated microscale technologies for low-cost, automated production of PET molecular imaging tracers for cancer research1R33CA240201-01 · under RFA-CA-18-003 | VAN DAM, ROBERT MICHAEL | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $379,082 | ZCA1 |
| 2019 | Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer1R33CA235302-01A1 · under RFA-CA-18-003 | BRITO, ILANA LAURENDE VLAMINCK, IWIJNZIPFEL, WARREN R | CORNELL UNIVERSITY, NY | $349,262 | ZCA1 |
| 2019 | Multiscale microscope for 3D cancer imaging in model organisms and organoids1R33CA235254-01 · under RFA-CA-18-003 | FIOLKA, RETO PAUL | UT SOUTHWESTERN MEDICAL CENTER, TX | $328,541 | ZCA1 |
| 2019 | Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia1R33CA235597-01A1 · under RFA-CA-18-003 | AUGUST, KEITHSOPER, STEVEN ALLAN | UNIVERSITY OF KANSAS LAWRENCE, KS | $241,587 | ZCA1 |
| 2018 | Pro-Codes: A novel vector and cell barcoding technology1R33CA223947-01A1 · under RFA-CA-17-011 | BROWN, BRIAN D | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $421,587 | ZCA1 |
| 2018 | Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform1R33CA223908-01 · under RFA-CA-17-011 | EVENS, ANDREW MHUANG, TONY JUNKONRY, TANIA TALI | NORTHEASTERN UNIVERSITY, MA | $421,501 | ZCA1 |
| 2018 | Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors1R33CA223904-01 · under RFA-CA-17-011 | CIMA, MICHAEL J | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $416,667 | ZCA1 |
| 2018 | An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer1R33CA225539-01 · under RFA-CA-17-011 | JIANG, NING JENNY | UNIVERSITY OF TEXAS AT AUSTIN, TX | $396,959 | ZCA1 |
| 2018 | CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer1R33CA225863-01 · under RFA-CA-17-011 | LU, JUN | YALE UNIVERSITY, CT | $395,674 | ZCA1 |
| 2018 | Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level1R33CA223581-01A1 · under RFA-CA-17-011 | CHENG, JI-XIN | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $390,880 | ZCA1 |
| 2018 | Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations1R33CA229023-01 · under RFA-CA-17-011 | TEWARI, MUNEESHWALTER, NILS G | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $388,440 | ZCA1 |
| 2018 | Multiplex matrix ELISA for T cell protein-interaction networks in cancer1R33CA228979-01 · under RFA-CA-17-011 | SCHRUM, ADAM G. | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $387,880 | ZCA1 |
| 2018 | Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods1R33CA222344-01 · under RFA-CA-17-011 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON, WA | $386,677 | ZCA1 |
| 2018 | High-throughput super-resolution imaging of chromatin structures at different epigenetic states1R33CA225494-01 · under RFA-CA-17-011 | LIU, YANG | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $351,864 | ZCA1 |
| 2017 | Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes1R33CA217652-01 · under RFA-CA-16-002 | MAKRIGIORGOS, G. MIKE | DANA-FARBER CANCER INST, MA | $456,746 | ZCA1 |
| 2017 | Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry1R33CA212973-01 · under RFA-CA-16-002 | YATES III, JOHN R | SCRIPPS RESEARCH INSTITUTE, THE, CA | $435,649 | ZCA1 |
| 2017 | Droplet microfluidic technology for single cell cancer genomics1R33CA212697-01 · under RFA-CA-16-002 | KLEIN, ALLON MOSHE | HARVARD MEDICAL SCHOOL, MA | $411,954 | ZCA1 |
| 2017 | High Resolution High Throughput Proteomics Platform for Cancer Research1R33CA217699-01 · under RFA-CA-16-002 | IBRAHIM, YEHIA | BATTELLE PACIFIC NORTHWEST LABORATORIES, WA | $410,858 | ZCA1 |
| 2017 | Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer1R33CA214333-01 · under RFA-CA-16-002 | GODWIN, ANDREW K.SAMUEL, GLENSONZENG, YONG | UNIVERSITY OF KANSAS LAWRENCE, KS | $400,098 | ZCA1 |
| 2017 | Next-generation MOWChIP-seq for high-throughput epigenomic profiling using clinically relevant samples1R33CA214176-01 · under RFA-CA-16-002 | LU, CHANG | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $391,723 | ZCA1 |
| 2017 | TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES1R33CA217700-01 · under RFA-CA-16-002 | DUNCAVAGE, ERIC JWALTER, MATTHEW J | WASHINGTON UNIVERSITY, MO | $379,725 | ZCA1 |
| 2017 | Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells1R33CA204704-01A1 · under RFA-CA-16-002 | WANG, YINGXIAO | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $376,821 | ZCA1 |
| 2017 | Cancer histology and QC via MUSE: Sample-sparing UV surface-excitation microscopy1R33CA202881-01A1 · under RFA-CA-16-002 | LEVENSON, RICHARD M. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $373,637 | ZCA1 |
| 2017 | LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics1R33CA212968-01 · under RFA-CA-16-002 | SINGH, ANKUR | CORNELL UNIVERSITY, NY | $371,216 | ZCA1 |
| 2017 | Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity1R33CA217780-01 · under RFA-CA-16-002 | PARKER, LAURIE L. | UNIVERSITY OF MINNESOTA, MN | $345,244 | ZCA1 |
| 2017 | Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis1R33CA204574-01A1 · under RFA-CA-16-002 | KELLEY, SHANA O | UNIVERSITY OF TORONTO, ON | $258,952 | ZCA1 |
| 2016 | Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology1R33CA206949-01 · under RFA-CA-15-003 | SPICER, TIMOTHY PATRICK | SCRIPPS FLORIDA, FL | $501,426 | ZCA1 |
| 2016 | Clinical implementation of single cell tumor transcriptome analysis1R33CA202820-01 · under RFA-CA-15-003 | REGEV, AVIV | BROAD INSTITUTE, INC., MA | $457,465 | ZCA1 |
| 2016 | Analysis of scant cancer cells in fine needle aspirates1R33CA202064-01 · under RFA-CA-15-003 | WEISSLEDER, MD, PHD, RALPH | MASSACHUSETTS GENERAL HOSPITAL, MA | $433,261 | ZCA1 |
| 2016 | A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers1R33CA202900-01 · under RFA-CA-15-003 | BREUNIG, JOSHUA JOHN | CEDARS-SINAI MEDICAL CENTER, CA | $418,128 | ZCA1 |
| 2016 | Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma1R33CA196470-01A1 · under RFA-CA-15-003 | LIN, QIAO | COLUMBIA UNIV NEW YORK MORNINGSIDE, NY | $394,518 | ZCA1 |
| 2016 | Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology1R33CA196458-01A1 · under RFA-CA-15-003 | BHARGAVA, ROHITCHEVILLE, JOHN C | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $387,693 | ZCA1 |
| 2016 | Charge sensitive optical detection for high-throughput study of small molecules1R33CA202834-01A1 · under RFA-CA-15-003 | TAO, NONGJIAN | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $381,382 | ZCA1 |
| 2016 | Online Raman Diagnostics of Oncometabolites1R33CA206922-01 · under RFA-CA-15-003 | SCHULTZ, ZACHARY | UNIVERSITY OF NOTRE DAME, IN | $363,875 | ZCA1 |
| 2016 | GESI: a novel technology for functional imaging in living cells1R33CA196445-01A1 · under RFA-CA-15-003 | LAM, KIT S | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $362,749 | ZCA1 |
| 2016 | Protein painting identifies therapeutic targets at protein-protein interfaces1R33CA206937-01 · under RFA-CA-15-003 | LIOTTA, LANCE ALLEN | GEORGE MASON UNIVERSITY, VA | $348,203 | ZCA1 |
| 2016 | High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug Testing1R33CA202867-01 · under RFA-CA-15-003 | NAGRATH, SUNITHARAMNATH, NITHYA | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $343,664 | ZCA1 |
| 2016 | A novel molecular assay for early detection and assessment of cancer risk1R33CA202898-01 · under RFA-CA-15-003 | QUEIMADO, LURDES | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $340,594 | ZCA1 |
| 2016 | Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors1R33CA206955-01 · under RFA-CA-15-003 | WEISS, GREGORY A. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $322,131 | ZCA1 |
| 2016 | Large-Scale Integration of Single Cell RNA-Seq and High-Content Imaging for Analyzing Drug Response in Cancer1R33CA202827-01 · under RFA-CA-15-003 | SIMS, PETER ALAN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $316,149 | ZCA1 |
| 2016 | Brillouin confocal microscopy for biomechanical studies of metastatic cascade in 3D microenvironments1R33CA204582-01 · under RFA-CA-15-003 | SCARCELLI, GIULIANO | UNIV OF MARYLAND, COLLEGE PARK, MD | $295,733 | ZCA1 |
| 2015 | Single cell cytokine analysis of circulating malignant hematopoietic cells1R33CA196411-01 · under RFA-CA-14-004 | FAN, RONGLEVINE, ROSS L | YALE UNIVERSITY, CT | $421,227 | ZCA1 |
| 2015 | High-throughput on-chip platform for interrogation of mitochondrial membrane potential and apoptosis1R33CA182384-01A1 · under RFA-CA-14-004 | BURKE, PETER J. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $412,541 | ZCA1 |
| 2015 | Noninvasive detection of circulating RNAs for lung cancer early detection and prognosis1R33CA191245-01A1 · under RFA-CA-14-004 | WU, YUN | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $411,504 | ZCA1 |
| 2015 | Development of a virion display (VirD) array to profile human GPCR interactions1R33CA186790-01A1 · under RFA-CA-14-004 | DESAI, PRASHANT JZHU, HENG | JOHNS HOPKINS UNIVERSITY, MD | $403,372 | ZCA1 |
| 2015 | A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes1R33CA191198-01 · under RFA-CA-14-004 | CARON, MARC G. | DUKE UNIVERSITY, NC | $389,963 | ZCA1 |
| 2015 | Using Adductomics to Characterize Exposures to Carcinogens1R33CA191159-01A1 · under RFA-CA-14-004 | RAPPAPORT, STEPHEN MORRIS | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $380,395 | ZCA1 |
| 2015 | Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations1R33CA192980-01 · under RFA-CA-14-004 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON, WA | $375,858 | ZCA1 |
| 2015 | Scalable Cancer Genomics via Nanocoding and Sequencing1R33CA182360-01A1 · under RFA-CA-14-004 | MA, JIANSCHWARTZ, DAVID C. | UNIVERSITY OF WISCONSIN-MADISON, WI | $372,503 | ZCA1 |
| 2015 | Fast interference-based super-resolution microscope for cancer mechanobiology1R33CA193043-01 · under RFA-CA-14-004 | ZIPFEL, WARREN R | CORNELL UNIVERSITY, NY | $364,273 | ZCA1 |
| 2015 | Single cell growth assay for residual cells in acute lymphoblastic leukemia1R33CA191143-01 · under RFA-CA-14-004 | MANALIS, SCOTT R | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $363,946 | ZCA1 |
| 2015 | RASL-Seq Expression Profiling of FFPE Tissues1R33CA183688-01A1 · under RFA-CA-14-004 | YEAKLEY, JOANNE MULLIGAN | BIOSPYDER TECHNOLOGIES, INC., CA | $363,706 | ZCA1 |
| 2015 | Validation and Advanced Development of Glycan Node Analysis in Lung Cancer Research1R33CA191110-01 · under RFA-CA-14-004 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $317,654 | ZCA1 |
| 2014 | Integrating mass cytometric and transcriptomic profiles of solid tumors1R33CA183692-01 · under RFA-CA-13-002 | WEISS, WILLIAM A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $408,712 | ZCA1 |
| 2014 | Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci1R33CA183659-01 · under RFA-CA-13-002 | ROBINSON, WILLIAM H | STANFORD UNIVERSITY, CA | $399,643 | ZCA1 |
| 2014 | Validation and Advanced Development of Duplex Sequencing1R33CA181771-01A1 · under RFA-CA-13-002 | LOEB, LAWRENCE A | UNIVERSITY OF WASHINGTON, WA | $384,923 | ZCA1 |
| 2014 | Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics1R33CA177333-01A1 · under RFA-CA-13-002 | FEDERSPIEL, MARK J | MAYO CLINIC ROCHESTER, MN | $375,008 | ZCA1 |
| 2014 | Non-Circulating Microparticles for Improved Localization and Resection Cancer1R33CA177449-01A1 · under RFA-CA-13-002 | BLAIR, SARAH L | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $361,766 | ZCA1 |
| 2014 | Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp1R33CA183671-01 · under RFA-CA-13-002 | PARKER, LAURIE L. | UNIVERSITY OF MINNESOTA, MN | $341,454 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.